| Financial Year |
March 31 2023 |
| Monetary Funds |
1,100,751,188.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
274,750,779.07 |
| Advances to Suppliers |
15,406,010.06 |
| Other Receivables |
31,234,750.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
708,849,918.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
263,236.64 |
| Total Current Assets |
2,131,255,882.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
49,742,307.04 |
| Fixed Assetes |
448,661,212.22 |
| Under-construction Projects |
2,152,986.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,566,375.42 |
| R&D expenses |
-- |
| Goodwill |
12,214,229.51 |
| Long-Term Deferred and Prepaid Expenses |
16,769,985.05 |
| Deferred Income Tax Assets |
56,564,011.36 |
| Other Non-Current Assets |
296,863.21 |
| Sub-Total of Non-Current Assets |
714,948,801.05 |
| Total Assets |
2,846,204,683.91 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
189,159,146.14 |
| Accounts Received In Advance |
2,369,089.61 |
| Employee Compensation Payable |
66,443,786.78 |
| Taxes Payable |
73,608,887.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
113,693,995.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,746,922.11 |
| Other Current Liabilities |
731,095.65 |
| Sub-Total of Current Liabilities |
497,422,505.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,570,715.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,540,502.61 |
| Total Liabilities |
565,963,008.30 |
| Paid-In Capital(Or Share Stock) |
409,924,000.00 |
| Capital Surplus |
781,667,090.83 |
| Surplus Reserve |
202,833,713.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
745,801,049.29 |
| Minority Stockholder's Interest |
139,693,597.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,140,548,078.25 |
| Owner's Equity（Stockholder's Equity） |
2,280,241,675.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,846,204,683.91 |
